(Q48121842)

8 February 2018

title

Electrophysiological effects of cholecystokinin octapeptide on identified rat nigrostriatal dopaminergic neurons (English)

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

31 December 2022

1 reference

1 reference

1 reference

electrophysiological effect

1 reference

A. S. Freeman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3359189

31 December 2022

L. A. Chiodo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3359189

31 December 2022

language of work or name

English

0 references

publication date

1 January 1988

1 reference

8 February 2018

26 January 1988

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3359189

full work available at URL

31 December 2022

number of pages

9

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:0006899388914837?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

https://api.elsevier.com/content/article/PII:0006899388914837?httpAccept=text/plain

31 December 2022

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

31 December 2022

1 reference

8 February 2018

volume

439

1 reference

8 February 2018

issue

1-2

1 reference

8 February 2018

page(s)

266-274

1 reference

8 February 2018

Proglumide: selective antagonism of excitatory effects of cholecystokinin in central nervous system

cites work

4

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

31 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Population response of midbrain dopaminergic neurons to neuroleptics: further studies on time course and nondopaminergic neuronal influences

31 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons

31 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Electrophysiological studies on the specificity of the cholecystokinin antagonist proglumide

31 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system.

31 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

The distribution and some connections of cholecystokinin neurons in the rat brain.

31 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Dopamine- and cholecystokinin-containing neurons of the crossed mesostriatal projection.

31 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Activity of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin

31 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

CCK nerve terminals in the rat striatal and limbic areas originate partly in the brain stem and partly in telencephalic structures

31 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--3. Evidence for electrotonic coupling.

31 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Dendro-dendritic synapses in substantia nigra: descriptions based on analysis of serial sections.

31 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Evidence for coexistence of dopamine and CCK in meso-limbic neurones

31 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing

31 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Distribution of cholecystokinin-like immunoreactivity in the nervous system. Co-existence with classical neurotransmitters and other neuropeptides.

31 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Cholecystokinin-like peptides potentiate apomorphine-induced inhibition of dopamine neurons

31 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Cholecystokinin-induced excitation in the substantia nigra: evidence for peripheral and central components.

31 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtype

31 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Additional evidence that small amounts of a peptide can cross the blood-brain barrier

31 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Effect of 6-hydroxydopamine lesions of the medial forebrain bundle on the distribution of cholecystokinin in rat forebrain.

31 December 2022

27

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Entry of opioid peptides into the central nervous system

31 December 2022

30

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Peptide-monoamine coexistence: Studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons

31 December 2022

32

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Distinct properties of cholecystokinin-8 and mixed dopamine-cholecystokinin-8 neurons innervating the nucleus accumbens.

31 December 2022

34

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

31 December 2022

Neuronal cholecystokinin

36

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons

31 December 2022

38

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists

31 December 2022

39

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Changes in brain cholecystokinin octapeptide following lesions of the medial forebrain bundle

31 December 2022

41

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

Blood-CSF barrier to CCK and effect of centrally administered bombesin on release of brain CCK.

31 December 2022

42

1 reference

https://api.crossref.org/works/10.1016/0006-8993(88)91483-7

31 December 2022

Identifiers

1 reference

8 February 2018

1 reference

8 February 2018